1,143
Views
0
CrossRef citations to date
0
Altmetric
Food Science & Technology

Bio-evaluation of alkaloids and saponins from bitter melon: Probing more desirable compound in treating hyperglycemia and hyperlipidemia

, ORCID Icon, , , , , , ORCID Icon, & ORCID Icon show all
Article: 2242634 | Received 03 Dec 2022, Accepted 26 Jul 2023, Published online: 28 Sep 2023

References

  • Abas, R., Das, S., & Thent, Z. C. (2015). Momordica charantia fruit extract improve subcellular changes in cardiovascular tissues of diabetic rats. Journal of Medical & Bioengineering, 4(5), 357–16. https://doi.org/10.12720/jomb.4.5.357-362
  • Abdollah, M., Zuki, A. B. Z., Goh, Y. M., Rezaeizadeh, A., & Noordin, M. M. (2010). The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats. African Journal of Biotechnology, 9(31), 5004–5012.
  • Abo-Ghanema, I., & Saleh, R. (2012). Some physiological effects of Momordica charantia and trigonella foenum-graecum extracts in diabetic rats as compared with Cidophage. International Journal of Animal and Veterinary Sciences, 6(4), 222–230. https://doi.org/10.5281/zenodo.1086261
  • Ahn, J., Choi, W., Kim, S., & Ha, T. (2011). Anti-diabetic effect of watermelon (Citrullus vulgaris Schrad) on streptozotocin-induced diabetic mice. Food Science & Biotechnology, 20(1), 251–254. https://doi.org/10.1007/s10068-011-0034-5
  • Akhtar, N., Khan, B. A., Majid, A., Khan, S., Mahmood, T., Gulfishan, G., & Saeed, T. (2011). Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits. Acta poloniae pharmaceutica, 68(6), 919–925.
  • Al-Neaimy, K. S. A. (2008). Comparative effect of metformin and glibenclamide on lipid profile in type 2 diabetic patients. Tikrit Journal of Pharmaceutical Sciences, 1(1), 46–50. https://www.iasj.net/iasj/download/d4a9c649dbfac3c3
  • Alshatwi, A. A., Al Obaaid, M. A., Al Sedairy, S. A., Al-Assaf, A. H., Zhang, J. J., & Lei, K. Y. (2010). Tomato powder is more protective than lycopene supplement against lipid peroxidation in rats. Nutrition Research, 30(1), 66–73. https://doi.org/10.1016/j.nutres.2009.12.002
  • Arshad, F., Saeed, M. S., Nadeem, M. T., Arshad, M. U., Nadeem, M. T., & Arshad, M. U. (2017). Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia). Lipids in Health and Disease, 16(1), 1–11. https://doi.org/10.1186/s12944-017-0602-7
  • Bano, F., Akthar, N., & Naz, H. (2011). Effect of the aqueous extract of Momordica charantia on body weight of rats. Journal of Basic & Applied Sciences, 7(1), 1–5.
  • Bhushan, M. S., Rao, C. H. V., Ojha, S. K., Vijayakumar, M., & Verma, A. (2010). An analytical review of plants for anti-diabetic activity with their phytoconstituent and mechanism of action. International Journal of Pharmaceutical Sciences and Research, 1(1), 29–46.
  • Biyani, M.K., Banavalikar, M.M., Suthar, A.C., Shahani, S., Sivakami, S. and Vidri, J. (2003). Antihyperglycemic effects of three extracts from Momordica charantia. Journal of Ethanopharmocology, 88(1), 107–111. https://doi.org/10.1016/S0378-8741(03)00184-3
  • Bortolotti, M., Mercatelli, D., & Polito, L. (2019). Momordica charantia, a nutraceutical approach for inflammatory related diseases. Frontiers in Pharmacology, 10, 486. https://doi.org/10.3389/fphar.2019.00486
  • Chen, Q., Chan, L. L., & Li, E. T. (2003). Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. The Journal of Nutrition, 133(4), 1088–1093. https://doi.org/10.1093/jn/133.4.1088
  • Chen, Y., Liu, Z. X., & Wu, C. S. (2010). Study on extracting technology of saponins from bitter melon. Guangzhou Chemical Industries, 38(1), 59–61.
  • Çiçek, S. S. (2022). Momordica charantia L.— diabetes-related bioactivities, quality control, and safety considerations. Frontiers in Pharmacology, 1801. https://doi.org/10.3389/fphar.2022.904643
  • Clouatre, D. L., Rao, S. N., & Preuss, H. G. (2011). Bitter melon extracts in diabetic and normal rats favorably influence blood glucose and blood pressure regulation. Journal of Medicinal Food, 14(12), 1496–1504. https://doi.org/10.1089/jmf.2010.0276
  • Cummings, D. E., & Overduin, J. (2007). Gastrointestinal regulation of food intake. Journal of Clinical Investigation, 117(1), 13–23. https://doi.org/10.1172/JCI30227
  • Dwijayanti, D. R., Okuyama, T., Okumura, T., Ikeya, Y., & Nishizawa, M. (2019). The anti-inflammatory effects of Indonesian and Japanese bitter melon (Momordica charantia L.) fruit extracts on interleukin-1β-treated hepatocytes. Functional Foods in Health and Disease, 9(1), 16–33. https://doi.org/10.31989/ffhd.v9i1.560
  • Dwijayanti, D. R., Shimada, T., Ishii, T., Okuyama, T., Ikeya, Y., Mukai, E., & Nishizawa, M. (2020). Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice. Phytotherapy Research, 34(6), 1338–1346. https://doi.org/10.1002/ptr.6600
  • Fang, E. F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V. A., Wong, J. H., & Ng, T. B. (2019). Emerging antitumor activities of the bitter melon (Momordica charantia). Current Protein & Peptide Science, 20(3), 296–301. https://doi.org/10.2174/1389203719666180622095800
  • Fernandes, N. P., Lagishetty, C. V., Panda, V. S., & Naik, S. R. (2007). An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complementary and Alternative Medicine, 7(1), 29. https://doi.org/10.1186/1472-6882-7-29
  • Gadang, V., Gilbert, W., Hettiararchchy, N., Horax, R., Katwa, L., & Devareddy, L. (2011). Dietary bitter melon seed increases peroxisome proliferator-activated receptor-γ gene expression in adipose tissue, down-regulates the nuclear factor-κB expression, and alleviates the symptoms associated with metabolic syndrome. Journal of Medicinal Food, 14(1–2), 86–93. https://doi.org/10.1089/jmf.2010.0010
  • Gao, Y., Li, X., Huang, Y., Chen, J., & Qiu, M. (2021). Bitter melon and diabetes mellitus. Food Reviews International, 39(1), 1–21. https://doi.org/10.1080/87559129.2021.1923733
  • Gayathry, K. S., & John, J. A. (2022). A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Production, Processing and Nutrition, 4(1), 10. https://doi.org/10.1186/s43014-022-00089-x
  • Gill, N. S., Rani, P., Arora, R., Dhawan, V., & Bali, M. (2012). Evaluation of antioxidant, antiinflammatory and antiulcer potential of Momordica charantia methanolic seed extract. Research Journal of Phytochemistry, 6(4), 1–9. https://doi.org/10.3923/rjphyto.2012.96.104
  • Habicht, S. D., Kind, V., Rudloff, S., Borsch, C., Mueller, A. S., Pallauf, J., Yang, R.-Y., & Krawinkel, M. B. (2011). Quantification of antidiabetic extracts and compounds in bitter gourd varieties. Food Chemistry, 126(1), 172–176. https://doi.org/10.1016/j.foodchem.2010.10.094
  • Harborne, J. B. (2005). Phytochemical methods. A guide to modern techniques of plant analysis (3rd ed.). Springer Pvt. Ltd.
  • Hazarika, R., Parida, P., Neog, B., & Yadav, R. N. S. (2012). Binding energy calculation of GSK-3 protein of human against some anti-diabetic compounds of Momordica charantia linn (bitter melon). Bioinformation, 8(6), 251. https://doi.org/10.6026/97320630008251
  • Hossain, M. A., Mostofa, M., Debnath, D., Alam, A. K. M. R., Yasmin, Z., & Moitry, N. F. (2012). Antihyperglycemic and antihyperlipidemic of Karala (Momordica charantia) fruits in streptozotocin induced diabetic rats. Journal of Environmental Science & Natural Resources, 5(1), 29–37. https://doi.org/10.3329/jesnr.v5i1.11550
  • Huang, H. L., Hong, Y. W., Wong, Y. H., Chen, Y. N., Chyuan, J. H., Huang, C. J., & Chao, P. M. (2008). Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. The British Journal of Nutrition, 99(2), 230–239. https://doi.org/10.1017/S0007114507793947
  • Hussain, M. S., Jahan, N., Rashid, M. M. O., Hossain, M. S., Chen, U., & Rahman, N. (2019). Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model. Heliyon, 5(5), e01739. https://doi.org/10.1016/j.heliyon.2019.e01739
  • International Diabetes Federation. (2021). International diabetes federation. IDF diabetes atlas (10thed.). www.diabetesatlas.org
  • Jafri, S. A., Ismail, M. S., & Zaman, G. (2009). Effect of Momordica charantia (karela) in alloxan induced diabetic rats. Pakistan Journal of Science, 61(4), 220–222.
  • Jeong, J., Lee, S., Hue, J., Lee, K., Nam, S. Y., & Yun, Y. W. (2008). Effect of bitter melon (Momordica Charantia) on antidiabetic activity in C57BL/6J db/db mice. Korean Journal of Veterinary Research, 48(3), 327–336.
  • Karagöz, I. K., Karagöz, A., Özkalaycı, F., Doğan, C., Kocabay, G., & Elbay, A. (2021, August). Relation between platelet reactivity levels and diabetic retinopathy stage in patient with type 2 diabetes mellitus by using multiplate whole blood aggregometry. Seminars in Ophthalmology, 36(5–6), 392–399. Taylor & Francis. https://doi.org/10.1080/08820538.2021.1893759
  • Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000). Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology & Metabolism, 85(7), 2402–2410. https://doi.org/10.1210/jcem.85.7.6661
  • Ketut, D. M., Adnyana, D. P. A., Rinaldhi, C. P., Octaviani, R. R., & Cempaka, D. K. S. (2019). The antidiabetic effect of bitter melon (Momordica charantia L.) extracts towards glucose concentration, langerhans islets, and leydig cells of hyperglycemic mice (Rattus norvegicus). EurAsian Journal of BioSciences, 13(2), 757–762. https://web.p.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=13079867&AN=149914670&h=ndz0mEnVLAxvNd8ZNN7QRWlI6RNQcxDqWzuTPutqoiJUDOFj4BQ8jXv%2bVdzNLQ2K3Xa%2fvW%2bH5csIDYNW52sFtA%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d13079867%26AN%3d149914670
  • Kim, J., Cho, H., Moon, S., Kim, K., & Ku, S. (2012). Synergic effects of bitter melon and β-glucan composition on STZ-Induced rat diabetes and its complications. Journal of Microbiology and Biotechnology, 22(1), 147–155. https://doi.org/10.4014/jmb.1106.06037
  • Kim, J. I., Paik, J. K., Kim, O. Y., Park, H. W., Lee, J. H., Jang, Y., & Lee, J. H. (2011). Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis, 215(1), 189–195. https://doi.org/10.1016/j.atherosclerosis.2010.11.036
  • Klomann, S. D., Mueller, A. S., Pallauf, J., & Krawinkel, M. B. (2010). Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice. The British Journal of Nutrition, 104(11), 1613–1620. https://doi.org/10.1017/S0007114510002680
  • Kole, C., Matsumura, H., & Behera, T. K. (Eds.). (2020). The bitter gourd genome. Springer. https://doi.org/10.1007/978-3-030-15062-4
  • Krawinkel, M. B., & Keding, G. B. (2006). Bitter Gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutrition Reviews, 7(7), 331–337. https://doi.org/10.1111/j.1753-4887.2006.tb00217.x
  • Li-Dong, T., Ming-Wei, Z., Si-Yuan, G., Rui-Fen, Z., Jian-Wei, C., Zhen-Cheng, W., Yan, Z., & Xiao-Jun, T. (2008). Comparison of saponin contents of different varieties of Momordica charantia L. and their inhibition on α-glucosidase activity. Scientia Agricultura sinica, 41(10), 3415–3421.
  • Liu, Z., Gong, J., Huang, W., Lu, F., Dong, H., & Ullah, R. (2021). The effect of Momordica charantia in the treatment of diabetes mellitus: A review. Evid Based Complement Altern Med, 2021, 1–14. https://doi.org/10.1155/2021/3796265
  • Li, Z., Xia, A., Li, S., Yang, G., Jin, W., Zhang, M., & Wang, S. (2020). The pharmacological properties and therapeutic use of bitter melon (Momordica charantia L.). Current Pharmacology Reports, 6(3), 103–109. https://doi.org/10.1007/s40495-020-00219-4
  • Lucas, E. A., Dumancas, G. G., Smith, B. J., Clarke, S. L., & Arjmandi, B. H. (2010). In bioactive foods in promoting health ( V. R. Preedy, Ed.). Academic Press. https://doi.org/10.1016/B978-0-12-374628-3.00035-9
  • Mahmood, A., Raja, G. K., Mahmood, T., Gulfraz, M., & Khanum, A. (2012). Isolation and characterization of antimicrobial activity conferring component (s) from seeds of bitter gourd (Momordica charantia). Journal of Medicinal Plants Research, 6(4), 566–573. https://doi.org/10.5897/JMPR10.613
  • Majumda, B., & Debnath, T. (2014). Immunomodulatory activity of ethanolic extract of bitter gourd (Momordica charantia) in experimental models. Journal of Biomedical and Pharmaceutical Research, 3(3), 59–63.
  • Matsui, S., Yamane, T., Takita, T., Oishi, Y., & Kobayashi-Hattori, K. (2013). The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver. Nutrition Research, 33(7), 580–585. https://doi.org/10.1016/j.nutres.2013.05.002
  • Mohammady, I., Elattar, S., Mohammed, S., & Ewais, M. (2012). An evaluation of anti-diabetic and anti-lipidemic properties of Momordica charantia (bitter melon) fruit extract in experimentally induced diabetes. Life Science Journal, 9(2), 363–374.
  • Obadoni, B. O., & Ochuko, P. O. (2001). Phytochemical studies and comparative efficacy of the crude extract of some homeostatic plants in Edo and Delta states of Nigeria. Global Journal of Pure and Applied Sciences, 8(2), 203–208. https://doi.org/10.4314/gjpas.v8i2.16033
  • Oishi, Y., Sakamoto, T., Udagawa, H., Taniguchi, H., Kobayashi-Hattori, K., Ozawa, Y., & Takita, T. (2007). Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Bioscience, Biotechnology, and Biochemistry, 71(3), 735–740. https://doi.org/10.1271/bbb.60570
  • Panda, B. C., Mondal, S., Devi, K. S. P., Maiti, T. K., Khatua, S., Acharya, K., & Islam, S. S. (2015). Pectic polysaccharide from the green fruits of Momordica charantia (Karela): Structural characterization and study of immunoenhancing and antioxidant properties. Carbohydrate Research, 401, 24–31. https://doi.org/10.1016/j.carres.2014.10.015
  • Poovitha, S., & Parani, M. (2016). In vitro and in vivo α-amylase and αglucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complementary and Alternative Medicine, 16(Suppl 1), 185. https://doi.org/10.1186/s12906-016-1085-1
  • Reyes, B. A. S., Bautista, N. D., Tanquilut, N. C., Anunciado, R. V., Leung, A. B., Sanchez, G. C., Magtoto, R. L., Castronuevo, P., Tsukamura, H., & Maeda, K. I. (2006). Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats. Journal of Ethnopharmacology, 105(1–2), 196–200. https://doi.org/10.1016/j.jep.2005.10.018
  • Rohajatien, U., Sriwahyuni, T., Estiasih, E., & Sriwahyuni, E. (2018). Bitter melon (Momordica charantia L) fruit decreased blood glucose level and improved lipid profile of streptozotocin induced hyperglycemia rats. Current Research in Nutrition and Food Science Journal, 6(2), 359–370. https://doi.org/10.12944/CRNFSJ.6.2.11
  • Sa’adah, N. N., & Nurhayati, A. P. D. (2020). Antihiperlipidemic activity of the methanolic extract of parijoto (medinilla speciosa) on the protein profile of hyperlipidemic rats.
  • Saad, D. Y., Soliman, M. M., Baiomy, A. A., Yassin, M. H., & El-Sawy, H. B. (2017). Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: Biochemical, molecular and histopathological study. BMC Complementary and Alternative Medicine, 17(1), 319. https://doi.org/10.1186/s12906-017-1833-x
  • Saeed, F., Afzaal, M., Niaz, B., Arshad, M. U., Tufail, T., Hussain, M. B., & Javed, A. (2018). Bitter melon (Momordica charantia): A natural healthy vegetable. International Journal of Food Properties, 21(1), 1270–1290. https://doi.org/10.1080/10942912.2018.1446023
  • Sathishsekar, D., & Subramanian, S. (2005). Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats. Asia Pacific Journal of Clinical Nutrition, 14(2), 153–158.
  • Sato, M., Ueda, T., Nagata, K., Shiratake, S., Tomoyori, H., Kawakami, M., Ozaki, Y., Okubo, H., Shirouchi, B., & Imaizumi, K. (2011). Dietary kakrol (Momordica dioica Roxb.) flesh inhibits triacylglycerol absorption and lowers the risk for development of fatty liver in rats. Experimental Biology and Medicine, 236(10), 1139–1146. https://doi.org/10.1258/ebm.2011.011037
  • Senanayake, G. V., Maruyama, M., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., & Ohta, H. (2004). The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets. Journal of Nutritional Science and Vitaminology, 50(4), 253–257. https://doi.org/10.3177/jnsv.50.253
  • Shetty, A. K., Kumar, G. S., Sambaiah, K., & Salimath, P. V. (2005). Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods for Human Nutrition, 60(3), 109–112. https://doi.org/10.1007/s11130-005-6837-x
  • Singh, N., & Gupta, M. (2007). Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian Journal of Experimental Biology, 45(12), 1055–1062.
  • Smail, M., Howarth, F., Abdulkhalek, S., Ismail, A. M., Singh, R. B., Hanoman, C. & Singh, J. (2020). Medicinal and anti-oxidant effects of Bitter Melon (Momordica charantia) in the treatment of diabetic cardiomyopathy. World Heart Journal, 12(3), 1–9. https://clok.uclan.ac.uk/35904/1/35904%20Proof%20for%20bitter%20melon2020.pdf
  • Steel, R. G. D., & Torrie, J. H. (1986). Principles and procedures of statistics: A biometrical approach. McGraw-Hill.
  • Sultan, F., Saeed, M. T., Ahmed, A., Riaz, S., Amarowicz, N., Bigiu, R., Manea, R., & Manea, R. (2021). Bitter melon (Momordica charantia L.) fruit bioactives charantin and vicine potential for diabetes prophylaxis and treatment. Plants, 10(4), 730. https://doi.org/10.3390/plants10040730
  • Sundaram, E. N., & Kumar, S. (2002). Bitter melon holds hope for treating diabetes. Homeopathic Society, 22, 4.
  • Temitope, A. G., Sheriff, O. L., Azeezat, Y. F., Taofik, A., & Fatimah, A. I. (2013). Cardioprotective properties of Momordica charantia in Albino Rats. African Journal of Scientific Research, 11(1), 600–610.
  • Tymoczko, J. L., Stryer, B. T., Stryer, L., & Berg, J. M. (2002). Biochemistry ( W. H. Freeman, Ed.). W.H. Freeman.
  • Uebanso, T., Arai, H., Taketani, Y., Fukaya, M., Yamamoto, H., Mizuno, A., Uryu, K., Hada, T., & Takeda, E. (2007). Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. Journal of Nutritional Science and Vitaminology (Tokyo), 53(6), 482–486. https://doi.org/10.3177/jnsv.53.482
  • Wang, Q., Deng, Y., Zhang, M., Zhang, R., Zhang, Y., Tang, X., Wei, Z., & Chi, J. (2011). Continuous extraction of saponin and polysaccharide from Momordica charantia L. and their inhibitory effect on α-glucosidase. Scientia Agricultura sinica, 44(19), 4058–4065.
  • Wang, S., Li, Z., Yang, G., Ho, C. T., & Li, S. (2017). Momordica charantia: A popular health-promoting vegetable with multifunctionality. Food & Function, 8(5), 1749–1762. https://doi.org/10.1039/C6FO01812B
  • WHO. (2021). Cardiovascular diseases (CVDs). Retrieved September 15, 2022, from http://www.int/news-room/factsheets/detail/cardiovascular-diseases(cvds)
  • Xiang, L., Huang, X., Chen, L., Rao, P., & Ke, L. (2007). The reparative effects of Momordica charantia Linn. extract on HIT-T15 pancreatic beta cells. Asia Pacific journal of clinical nutrition, 16(1), 249–252. https://doi.org/10.5281/zenodo.1086261
  • Youn, K. S., Park, E. H., & Yoon, K. Y. (2019). Quality characteristics and antioxidant activity of bitter melon (Momordica charantia L.) dried by different methods. Korean Journal of Food Preservation, 26(2), 185–193. https://doi.org/10.11002/kjfp.2019.26.2.185
  • Yuan, X. Q., Yuan, C., & Liu, H. M. (2012). Hypoglycemic effect of Momordica charantia L. Var. abbreviata ser. protein hydrolysate prepared with alcalase. Applied Mechanics & Materials, 195-196, 324–329. https://doi.org/10.4028/www.scientific.net/AMM.195-196.324
  • Zawada, A., Machowiak, A., Rychter, A. M., Ratajczak, A. E., Szymczak-Tomczak, A., Dobrowolska, A., & Krela-Ka ´zmierczak, I. (2022). Accumulation of advanced glycation end-products in the body and dietary habits. Nutrients, 14(19), 3982. https://doi.org/10.3390/nu14193982
  • Zhang, F., Zhang, X., Yu, J., Tan, Y., Guo, P., & Wu, C. (2020). The gut microbiota confers the lipid-lowering effect of bitter melon (Momordica charantia L.) in high-fat diet (HFD)-Induced hyperlipidemic mice. Biomedicine & Pharmacotherapy, 131, 110667. https://doi.org/10.1016/j.biopha.2020.110667